TITLE

Use of Drug-Eluting Stents in Patients With Coronary Artery Disease and Renal Insufficiency

AUTHOR(S)
El-Menyar, Ayman A.; Al Suwaidi, Jassim; Holmes Jr, David R.
PUB. DATE
February 2010
SOURCE
Mayo Clinic Proceedings;Feb2010, Vol. 85 Issue 2, p165
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Renal insufficiency (RI) has been shown to be associated with increased major adverse cardiovascular events after percutaneous coronary intervention. We reviewed the impact of RI on the pathogenesis of coronary artery disease and outcomes after percutaneous coronary intervention In the form of drug-eluting stent (DES) implantation in these high-risk patients. We searched the English-language literature indexed in MEDLINE, Scopus, and EBSCO Host research databases from 1990 through January 2009, usIng as search terms coronary revascularization, drug-eluting stent, and renal insufficiency. Studies that assessed DES Implantation in patients with various degrees of RI were selected for review. Most of the available data were extracted from observational studies, and data from randomized trials formed the basis of a post hoc analysis. The outcomes after coronary revascularization were less favorable in patients with RI than in those with normal renal function. In patients with RI, DES implantation yielded better outcomes than did use of bare-metal stents. Randomized trials are needed to define optimal treatment of these high-risk patients with coronary artery disease.
ACCESSION #
48143759

 

Related Articles

  • Percutaneous Coronary Intervention.  // Current Medical Literature: Cardiology;2008, Vol. 27 Issue 2, p53 

    The article discusses various research being done on percutaneous coronary intervention. They include a comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent, with reference to a study by A. Miyazawa et al in a 2008 issue of the "American Heart Journal," and...

  • Will Stent Revascularization Replace Coronary Artery Bypass Grafting? Wilson, James M. // Texas Heart Institute Journal;2012, Vol. 39 Issue 6, p856 

    The article explores the outcomes of stenting as an option for revascularization in patients with coronary artery disease (CAD). It relates the mixed results of percutaneous transluminal coronary angioplasty. It describes the short-term and long-term outcomes from the use of bare-metal stents....

  • JAMA study finds benefits of DES outweigh the risks. Pedersen, Amanda // Medical Device Daily;6/30/2008, Vol. 12 Issue 125, p1 

    The article reports on the benefits of drug-eluting stents (DES) which outweigh an increased risk of stent thrombosis associated with it based on a study by David Malenka et al published in the June 25, 2008 issue of "Journal of the American Medical Association (JAMA). The study noted that the...

  • Diagnostic specificity and prognostic value of cardiac troponins in asymptomatic chronic haemodialysis patients: a three year prospective study. Troyanov, S.; Ly, Q. H.; Schampaert, E.; Ammann, H.; Lalumière, G.; Madore, F.; Quérin, S. // Heart;Sep2005, Vol. 91 Issue 9, p1227 

    This article focuses on a study which determines diagnostic specificity and prognostic value of cardiac troponins in asymptomatic chronic haemodialysis patients. Diagnosis and risk stratification of coronary artery disease are key issues in the management of haemodialysis patients. In patients...

  • Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Foley, Robert N.; Parfrey, Patrick S.; Harnett, John D.; Kent, Gloria M.; Martin, Christopher J.; Murray, David C.; Barre, Paul E. // Kidney International;Jan1995, Vol. 47 Issue 1, p186 

    End stage renal disease (ESRD) patients have a high cardiovascular mortality rate. Precise estimates of the prevalence, risk factors and prognosis of different manifestations of cardiac disease are unavailable. In this study a prospective cohort of 433 ESRD patients was followed from the start...

  • Prevention of Radiocontrast-Induced Nephropathy after Coronary Angiography: N-Acetylcysteine plus Saline Hydration versus Saline Hydration. Hassan, Yahaya; Zainal, Zainol A.; Aziz, Noorizan A.; Al-Jabi, Samah W.; Ismail, Omar // Tropical Journal of Pharmaceutical Research;Apr2011, Vol. 10 Issue 2, p133 

    Purpose: To compare the incidence of radiocontrast-induced nephropathy (RCIN) in patients undergoing coronary angiography pretreated with N-acetylcysteine NAC plus saline hydration or saline hydration alone and to determine the association between various risk factors and RCIN. Methods: Patients...

  • Targets of blood pressure. Liebl, Robert // Nephrology Dialysis Transplantation;Apr2011, Vol. 26 Issue 4, p1441 

    No abstract available.

  • Renal Function and Risk Factors of Moderate to Severe Chronic Kidney Disease in Golestan Province, Northeast of Iran. Najafi, Iraj; Attari, Fatemeh; Islami, Farhad; Shakeri, Ramin; Malekzadeh, Fatemeh; Salahi, Rasool; Gharavi, Mina Yapan; Hosseini, Mostafa; Broumand, Behrooz; Haghighi, Ali Nobakht; Larijani, Bagher; Malekzadeh, Reza // PLoS ONE;2010, Vol. 5 Issue 12, p1 

    Introduction: The incidence of end-stage renal disease is increasing worldwide. Earlier studies reported high prevalence rates of obesity and hypertension, two major risk factors of chronic kidney disease (CKD), in Golestan Province, Iran. We aimed to investigate prevalence of moderate to severe...

  • Managing ESRD following MI. Gould, Teddie // Drug Topics;6/20/2005, Vol. 149 Issue 12, DRUG TOPIC FOR THE HEALTH-SYSTEM p 

    This article presents the case of managing a 50 year-old man who has end-stage renal disease following myocardial infarction. The first pharmacist suggests that effective management of secondary hyperparathyroidism requires knowledge of prior parathyroid hormone (PTH), calcium, and phosphorus...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics